Eagle Genomics Wins as AI Champion in Business Weekly 2021 Awards
Award recognises contribution of AI-augmented knowledge discovery platform e[datascientist]™ in driving digital reinvention of the life sciences
Cambridge, UK – 30 September, 2021 – Eagle Genomics, a pioneer in applying network science to biology, has been recognised as the ‘AI Champion’ winner in Business Weekly’s 2021 Awards. The Award recognises the role of Eagle Genomics and its AI-augmented knowledge discovery platform, e[datascientist] in enabling next-generation product innovation for large enterprises across a range of industries by harnessing insights from multi-dimensional life sciences data.
When announcing the Awards shortlist earlier this year, Business Weekly, which reports on the latest innovation coming out of Cambridge to a global audience, highlighted Eagle Genomics’ innovation at the intersection of biology, data sciences and bioinformatics, and how this is helping drive the digital reinvention of R&D. Over the last decade, Eagle Genomics has worked with emblematic Fortune 500 Enterprises in the healthcare, personal care & beauty and agritech sectors, enabling them to deliver game-changing, sustainable products and technologies to their respective markets using the e[datascientist] platform.
Commenting on the win, Anthony Finbow, CEO, Eagle Genomics, said: "We are thrilled to be recognised by the Business Weekly Awards this year. We are immensely proud of our work and our rapidly growing global success, and at the same time are appreciative of the impressive company we keep in the Cambridge cluster alongside other notable AI and DeepTech companies. We are excited to be using our platform to help tackle the world’s Grand Challenges, to help realise a positive impact for our planet and society.”
Eagle Genomics continues on its sharp growth trajectory, with its platform continuing to evolve as the burgeoning global life sciences knowledge discovery hub. This includes delivering insights on the role of the microbiome and its complex, multi-dimensional data in health, wellness and global sustainability. Yesterday, 29 September, the Company announced its new knowledge partnership with the Earlham Institute, focused on providing critical tools required to analyse, explore and exploit microbiome data - combining open science with commercial R&D.
AI and DeepTech are a recognised strength for Cambridge on the global stage, attracting the interest of investors globally. ‘AI Champion’ was one of two important new categories in this year’s Business Weekly Awards. Eagle Genomics will be presented with the Award at a ceremony on 15 October at St John’s Innovation Centre, Cambridge, UK.